Bruno Landi

11.2k total citations · 4 hit papers
70 papers, 8.3k citations indexed

About

Bruno Landi is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bruno Landi has authored 70 papers receiving a total of 8.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 29 papers in Surgery and 29 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bruno Landi's work include Gastrointestinal Tumor Research and Treatment (19 papers), Colorectal Cancer Treatments and Studies (17 papers) and Gastric Cancer Management and Outcomes (16 papers). Bruno Landi is often cited by papers focused on Gastrointestinal Tumor Research and Treatment (19 papers), Colorectal Cancer Treatments and Studies (17 papers) and Gastric Cancer Management and Outcomes (16 papers). Bruno Landi collaborates with scholars based in France, United States and Italy. Bruno Landi's co-authors include Pierre Laurent‐Puig, Philippe Rougier, Christophe Louvet, Jean‐Baptiste Bachet, Astrid Lièvre, Valérie Boige, Michel Ducreux, Thierry André, Delphine Le Corre and Jean‐François Emile and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Oncogene.

In The Last Decade

Bruno Landi

68 papers receiving 8.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study

2003 2.3k citations Christophe Tournigand, Thierry André et al. Journal of Clinical Oncology profile →
KRAS Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer

2006 1.7k citations Astrid Lièvre, Jean‐Baptiste Bachet et al. Cancer Research profile →
KRAS Mutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab

2008 1.1k citations Astrid Lièvre, Jean‐Baptiste Bachet et al. Journal of Clinical Oncology profile →
Analysis of PTEN , BRAF , and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon Cancer

2009 529 citations Pierre Laurent‐Puig, Anne Cayre et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Bruno Landi

Since Specialization

Citations

This map shows the geographic impact of Bruno Landi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno Landi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno Landi more than expected).

Fields of papers citing papers by Bruno Landi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruno Landi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno Landi. The network helps show where Bruno Landi may publish in the future.

Co-authorship network of co-authors of Bruno Landi

This figure shows the co-authorship network connecting the top 25 collaborators of Bruno Landi. A scholar is included among the top collaborators of Bruno Landi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruno Landi. Bruno Landi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Integration of elicited expert information via a power prior in Bayesian variable selection: Application to colon cancer data 2019 ·Statistical Methods in Medical Research ·(unknown), Moreno Ursino, Peter F. Thall, Bruno Landi, Céline Lepère, Simon Pernot, Anita Burgun, Julien Taı̈eb, Aziz Zaanan, Sarah Zohar, Anne‐Sophie Jannot	7
2	Gastrointestinal stromal tumours (GISTs): French Intergroup Clinical Practice Guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO) 2019 ·Digestive and Liver Disease ·Bruno Landi, Jean‐Yves Blay, Sylvie Bonvalot, (unknown), Jean Michel Coindre, Jean‐François Emile, Vincent Hautefeuille, Charles Honoré, É. Lartigau, Georges Mantion, Marc Pracht, Axel Le Cesne, Michel Ducreux, Olivier Bouché	49
3	5-FU or mitomycin C hepatic arterial infusion after failure of arterial oxaliplatin in patients with colorectal cancer unresectable liver metastases 2017 ·Clinics and Research in Hepatology and Gastroenterology ·Simon Pernot, (unknown), (unknown), G. Amouyal, Marc Sapoval, (unknown), Bruno Landi, (unknown), Céline Lepère, Olivier Pellerin, Julien Taı̈eb	6
4	Safety and efficacy of palliative systemic chemotherapy combined with colorectal self-expandable metallic stents in advanced colorectal cancer: A multicenter study 2015 ·Clinics and Research in Hepatology and Gastroenterology ·(unknown), Antoine Charachon, Christophe Locher, Thomas Aparicio, Emmanuel Mitry, (unknown), Bruno Landi, Étienne Dorval, Driffa Moussata, Thierry Lecomte	17
5	Clinical Relevance of KRAS -Mutated Subclones Detected with Picodroplet Digital PCR in Advanced Colorectal Cancer Treated with Anti-EGFR Therapy 2014 ·Clinical Cancer Research ·Pierre Laurent‐Puig, Deniz Pekin, Corinne Normand, Steve K. Kotsopoulos, Philippe Nizard, Karla Perez‐Toralla, R. Kevin Rowell, Jeff Olson, Preethi Srinivasan, Delphine Le Corre, (unknown), (unknown), Xinyu Li, Darren R. Link, Olivier Bouché, Jean‐François Emile, Bruno Landi, Valérie Boige, J. Brian Hutchison, Valérie Taly	118
6	Biweekly docetaxel, fluorouracil, leucovorin, oxaliplatin (TEF) as first-line treatment for advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: safety and efficacy in a multicenter cohort 2013 ·Gastric Cancer ·Simon Pernot, Emmanuel Mitry, Emmanuelle Samalin, Laëtitia Dahan, Cécile Dalban, Marc Ychou, Jean‐François Seitz, (unknown), Thibault Mazard, Aziz Zaanan, Céline Lepère, Jean-Nicolas Vaillant, Bruno Landi, Philippe Rougier, Julien Taı̈eb	14
7	Management of gastrointestinal stromal tumours of limited size: Proposals from a French panel of physicians 2011 ·Digestive and Liver Disease ·Bruno Landi, Olivier Bouché, Rosine Guimbaud, Thomas Aparicio, Anne Berger, Sylvie Bonvalot, Bruno Buecher, Jean‐Yves Blay, Christian Boustière, (unknown), Jean‐François Emile, Marc Giovannini, Thierry Lecomte, Axel Le Cesne, Geneviève Monges, Bertrand Napoléon, Laurent Palazzo, Jean‐Alain Chayvialle	4
8	Medical treatment of pancreatic cancer: New hopes after 10 years of gemcitabine 2011 ·Clinics and Research in Hepatology and Gastroenterology ·Isabelle Trouilloud, Olivier Dubreuil, Tarek Boussaha, Céline Lepère, Bruno Landi, Aziz Zaanan, Jean‐Baptiste Bachet, Julien Taı̈eb	12
9	Analysis of PTEN , BRAF , and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon Cancer breakdown → 2009 ·Journal of Clinical Oncology ·Pierre Laurent‐Puig, Anne Cayre, Gilles Manceau, Emmanuel Buc, Jean‐Baptiste Bachet, Thierry Lecomte, Philippe Rougier, Astrid Lièvre, Bruno Landi, Valérie Boige, Michel Ducreux, Marc Ychou, Frédéric Bibeau, Olivier Bouché, Julia Reid, Steven Stone, Frédérique Penault‐Llorca	529
10	The role of endosonography in submucosal tumours 2009 ·Best Practice & Research Clinical Gastroenterology ·Bruno Landi, Laurent Palazzo	50
11	KRAS Mutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab breakdown → 2008 ·Journal of Clinical Oncology ·Astrid Lièvre, Jean‐Baptiste Bachet, Valérie Boige, Anne Cayre, Delphine Le Corre, Emmanuel Buc, Marc Ychou, Olivier Bouché, Bruno Landi, Christophe Louvet, Thierry André, Frédéric Bibeau, Marie-Danièle Diébold, Philippe Rougier, Michel Ducreux, Gorana Tomasic, Jean‐François Emile, Frédérique Penault–Llorca, Pierre Laurent‐Puig	1141
12	KRAS mutations in colorectal cancer is a predictive factor of response and progression free survival in patients treated with Cetuximab. 2007 ·Cancer Research ·Astrid Lièvre, Jean‐Baptiste Bachet, Marc Ychou, Olivier Bouché, Denis Pezet, Valérie Boige, Bruno Landi, Christophe Louvet, Jean‐François Emile, Frédéric Bibeau, (unknown), Gorana Tomasic, Jean‐François Côté, Jean–François Fléjou, Philippe Rougier, (unknown), Pierre Laurent‐Puig	7
13	Endoscopic management of a large choledochocele associated with choledocholithiasis 2007 ·Gastroentérologie Clinique et Biologique ·Anne Berger, Richard Douard, Bruno Landi, (unknown), Jean–Marc Canard, Christophe Cellier, Paul‐Henri Cugnenc	7
14	Cetuximab efficacy in patients treated routinely in university hospitals 2007 ·Gastroentérologie Clinique et Biologique ·Jean‐Baptiste Bachet, Pauline Afchain, Christophe Fermanian, Mohamed Bouchahda, Emmanuel Mitry, Bruno Landi, Thierry André, Astrid Lièvre, Christophe Louvet, Philippe Aegerter, Françis Lévi, Philippe Rougier	3
15	Absence of mutation in the putative tumor-suppressor gene KLF6 in colorectal cancers 2005 ·Oncogene ·Astrid Lièvre, Bruno Landi, Jean‐François Côté, Nicolas Veyrie, Jessica Zucman‐Rossi, Anne Berger, Pierre Laurent‐Puig	30
16	FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study breakdown → 2003 ·Journal of Clinical Oncology ·Christophe Tournigand, Thierry André, Emmanuel Achille, Gérard Lledo, (unknown), D. Méry-Mignard, Emmanuel Quinaux, C. Couteau, Marc Buyse, G. Ganem, Bruno Landi, Philippe Colin, Christophe Louvet, Aimery de Gramont	2290
17	Detection of free‐circulating tumor‐associated DNA in plasma of colorectal cancer patients and its association with prognosis 2002 ·International Journal of Cancer ·Thierry Lecomte, Anne Berger, Franck Zinzindohoué, (unknown), Bruno Landi, Hélène Blons, Philippe Beaune, Paul‐Henri Cugnenc, Pierre Laurent‐Puig	245
18	AMARYLLIS: an evaluation experiment on search engines in a French-speaching context 1998 ·Language Resources and Evaluation ·Bruno Landi, (unknown), (unknown), Laurent Schmitt	4
19	Gluten-Free Diet Induces Regression of T-Cell Activation in the Rectal Mucosa of Patients With Celiac Disease 1998 ·The American Journal of Gastroenterology ·Christophe Cellier, (unknown), Natacha Patey, M Leborgne, Philippe Marteau, Bruno Landi, Nadine Cerf–Bensussan, Jean–Philippe Barbier, Nicole Brousse	20
20	Antiphospholipid syndrome as the second cause of non-tumorous Budd-Chiari syndrome 1994 ·Journal of Hepatology ·S. Pelletier, Bruno Landi, (unknown), (unknown), A Coutellier, (unknown), (unknown), S. Herson, Dominique Valla	62

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact